Leveraging aggregated data from patient communities to improve cancer care


For data to be truly valuable, it must take into consideration all the facets of the patient’s life. That will allow researchers to uncover new patterns in cancer prognosis, diagnosis and treatment.

Cancer research is one of the mostly heavily invested areas of medical research, with more than $5 billion spent on exploring and developing new therapeutics and treatment options in the U.S. annually. Given that more than 1.7 million people are diagnosed with cancer in the U.S. every year, this research is critical to prolong survival and improve quality of life for patients.

While a significant element of cancer research relies on patient data, much of the available data is limited in quantity and scope. Currently, this type of information is primarily obtained from labs or clinical trials, limiting analyses to small cohorts of patients, which significantly affects the results obtained. Additionally, these controlled environments can produce synthetic outcomes and data that may not be reflective of real-life situations.

Continue reading >

Belong.Life is a leading global tech provider of high-engagement patient communities and care platforms, supporting millions of patients worldwide.

Among Belong.Life’s brands are the world’s largest social and professional networks for cancer patients (Belong – Beating Cancer Together) and multiple sclerosis patients (BelongMS), as well as i-Belong, BelongIBD, BelongPSOCoronApp (in selected countries), and more.

Belong.Life’s mission is to improve quality of life and quality of care worldwide through technology, engagement, data, and AI.

Skip to content